BAX and diabetes mellitus: While the untreated and the empty vector treated cohorts reached 100% diabetes incidence (except the mVa + BAX that reached 90%), there was a significantly lower incidence of diabetes in the ADi-100 1:2- and 1:4-treated cohorts of only 20% at 15 and 23 weeks, respectively (Figure 2).